News

The anti-inflammatory molecule interleukin (IL)-4 contributes to the neurodegeneration observed in Parkinson’s disease, a study in rats reports. The research, “Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigra in vivo,” was published in the journal Experimental Neurobiology. Parkinson’s is characterized by the progressive…

Specific microRNAs that are contained in tiny, cell-derived vesicles called exosomes may be biomarkers of Parkinson’s disease, according to a study. The study, “Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson’s disease,” was published in the journal European Review for Medical and Pharmacological Sciences. MicroRNAs (miRNAs)…

Offering specialized teams of health-care professionals, and the latest treatments, three centers have been added to the Centers of Excellence in Parkinson’s Care, increasing the number of facilities globally to 45, the Parkinson’s Foundation announced. The new centers include the Cleveland Clinic, the Medical University of South…